13F-HR/A filed by Lamond Capital Partners LLC
Lamond Capital Partners LLC filed this 13F-HR/A for the quarter ended 2015-12-31, filed 2016-02-09, with 7 holding rows worth $66,914,000.
- Accession
- 0001542550-16-000008
- Filer
- CIK 1542550
- Filed
- 2016-02-09
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2015
A holdings report, amendment of type restatement, 7 entries on the cover page, a total value of $66,914,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $66,914,000 with VALUE read as thousands by filing date, 13F file number 028-15156. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Oracle Corporation | 68389X105 | COM | 500,000 | $18,265,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 300,000 | $17,772,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 220,780 | $17,309,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 75,000 | $12,175,000 | thousands by filing date | |
| IGNYTA INC | 451731103 | COM | 46,721 | $626,000 | thousands by filing date | |
| ZELTIQ AESTHETICS INC | 98933Q108 | COM | 16,119 | $460,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 100,000 | $307,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001542550-16-000007 | superseded | 2016-02-09 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001542550-16-000008 | this filing | 2016-02-09 | acceptance time not in the bulk data set |